Authors/Disclosures
|
Larry B. Goldstein, MD, FAHA, FAAN
(University of Kentucky)
|
The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care. |
|
J. A. Fraser, MD
|
Dr. Fraser has nothing to disclose. |
|
Sophia Ryan, MD
|
Dr. Ryan has nothing to disclose. |
|
Mithila Fadia, MBBS
(Avance Neurology)
|
No disclosure on file |
|
Laura Lennihan, MD, FAAN
(Neurological Institute of New York)
|
No disclosure on file |
|
|
No disclosure on file |
|
Meheroz H. Rabadi, MD, FAAN
(Dept of VA Medical Center #127)
|
Dr. Rabadi has nothing to disclose. |
|
Claire S. Jacobs, MD
(Vertex Pharmaceutical)
|
No disclosure on file |
|
|
No disclosure on file |
|
Adam B. Cohen, MD
(Massachusetts General Hospital)
|
Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison. |
|
Eyal Y. Kimchi, MD, PhD
(Northwestern University)
|
The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH. |
|
|
No disclosure on file |